Additional file 2: Table S3. of IL-10 and integrin signaling pathways are associated with head and neck cancer progression

Putative Differential Expression (DE) between HNSCC TCGA Annotated Progressors and NonProgressors (False Discovery Rate (FDR) < 0.05). CTCF binding site annotation was from CTCFBSDB 2.0. (DOCX 489 kb

Additional file 1: Table S1. of IL-10 and integrin signaling pathways are associated with head and neck cancer progression

Demographics for TCGA HNSCC Progressors. Table S2. Demographics for TCGA HNSCC Non-progressors. (DOCX 484 kb

Additional file 3: Table S4. of IL-10 and integrin signaling pathways are associated with head and neck cancer progression

Pathways significantly enriched for differentially expressed (DE) genes between TCGA HNSCC progressors and nonprogressors. FDR = False Discovery Rate. Table S5. Pathways significantly enriched for differentially expressed (DE) genes between TCGA HNSCC progressors and nonprogressors who were assigned radiation treatment. FDR = False Discovery Rate. (DOCX 488 kb

Additional file 2: of Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma

Table S1. Relative methylation levels of mgmiRs in human HNSCC cell lines and normal head and neck cell lines. Table S2. Relative methylation level in tissues from 189 HNSCC patients and 92 normal controls. Table S3. Univariate and multivariable logistic regression with continuous variables in tissues. Table S4. Relative methylation level in saliva from 86 HNSCC patients and 108 normal controls. Table S5. Univariate and multivariable logistic regression with continuous variables in saliva. (DOCX 42 kb